SILO — Silo Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $3.36m
- -$3.72m
- $0.07m
- 16
- 26
- 32
- 13
Annual cashflow statement for Silo Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.04 | 3.9 | -3.91 | -3.7 | -4.39 |
| Amortisation | |||||
| Non-Cash Items | 1.97 | -6.89 | 0.486 | 0.177 | 0.001 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.087 | 0.705 | -0.075 | 0.299 | 0.552 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.16 | -2.28 | -3.5 | -3.22 | -3.83 |
| Other Investing Cash Flow Items | 0.039 | 7.19 | 0.087 | -4.15 | 0.974 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.039 | 7.19 | 0.087 | -4.15 | 0.974 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.13 | 3.79 | 4.94 | -0.471 | 3.24 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.02 | 8.71 | 1.53 | -7.84 | 0.381 |